Frontiers in Opioid Pharmacotherapy
Opioids have been the mainstay of pain therapy for thousands of years. Recent decades have seen tidal shifts in opioid use for acute, postoperative, chronic, neuropathic, and cancer pain, as emphasis on adequate pain treatment has grown. Opioid-related problems, including addiction, diversion, and overdose, have also grown concurrently with increased clinical use, particularly for chronic pain. Changes in individual practice, group guidelines, and policy recommendations, all aimed at stemming the tide of abuse and diversion, have rapidly emerged. Concurrently, there have been recent giant leaps in understanding and application of opioid pharmacology. These discoveries have challenged and sometimes reversed decades of “conventional wisdom”. New concepts in opioid pharmacology have spawned major new efforts in drug discovery, towards the development of opioids with greater clinical effectiveness and/or diminished side effects, and may also change the clinical use of existing opioids. New drugs are advancing through clinical trials, intended for pain, as well as for itch and depression, and other therapeutic areas. To feature these discoveries, the Anesthesiology Journal Symposium at the ASA 2017 annual meeting in Boston, MA, will be “Frontiers in Opioid Pharmacotherapy”.
The journal Anesthesiology also announces a themed issue, “Frontiers in Opioid Pharmacotherapy”, complementary to the Journal Symposium. Guest Editors will be Executive Editor James Rathmell, M.D., and Editor-in-Chief Evan D. Kharasch, M.D., Ph.D. Anesthesiology issues this broad call for papers reporting original research on the issue theme. All opioid pharmacology research, in anesthesia, pain and related fields, encompassing basic, translational, clinical, and population/outcomes research, is welcome. Submission deadline is August 1, 2017. Submitting a paper does not require attendance at the ANESTHESIOLOGY 2017 meeting in Boston.